OptiNose (OPTN) & Editas Medicine (EDIT) Head-To-Head SurveyThe Ledger GazetteIt is developing a genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR) technology. CRISPR uses a protein-ribonucleic acid… Continue reading
Popular Mechanics |
Most People May Already Be Immune to CRISPR
Popular Mechanics The gene-editing technology CRISPR has the potential to change everything about medicine. With CRISPR, scientists and doctors can potentially edit a person’s genome on the fly, fixing all manner of genetic diseases with a simple, non-invasive procedure … Microsoft Wants to Use Artificial Intelligence to Make CRISPR More AccurateGizmodo Microsoft AI is being used to improve CRISPR accuracyYahoo Finance UK |
|
Rare melanoma type highly responsive to immunotherapy
EurekAlert (press release) However, based on anecdotal reports of favorable responses, a group of researchers including Moffitt’s Zeynep Eroglu, M.D., Jane Messina, M.D., and Dae Won Kim, M.D., hypothesized that patients with desmoplastic melanoma may be more responsive to anti … Immunotherapy Highly Effective in Treatment of Rare Skin Cancer, Study FindsNewswise (press release) |
OncLive |
Considerations for Autologous Stem Cell Transplantation
OncLive I’m kind of a minimalist from the standpoint of, if patients are doing well and are in remission, we’ve moved away from scans in a lot of situations in large cell lymphoma. Once you have a negative PET scan and end treatment, I think there’s an … |